ARTA
ARMP icon

A.R.T. Advisors’s Armata Pharmaceuticals ARMP Stock Holding History

A.R.T. Advisors’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-724
Closed -$11K – 1386
2018
Q2 		$11K Buy
+724
New +$11.8K ﹤0.01% 1369
2018
Q1 		– Sell
-4,651
Closed -$65K – 1478
2017
Q4 		$65K Buy
4,651
+424
+10% +$6.26K ﹤0.01% 1283
2017
Q3 		$53K Buy
4,227
+1,223
+41% +$15.7K ﹤0.01% 1254
2017
Q2 		$32K Buy
+3,004
New +$72.9K ﹤0.01% 1328

Other funds holding ARMP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SXL
Summit X LLC Chesterfield, Missouri $536M AUM 15.36% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

A.R.T. Advisors's ARMP Position: Q3 2018 in Review

A.R.T. Advisors sold out of Armata Pharmaceuticals (ARMP) in Q3 2018, closing a stake of 724 shares — an estimated $11K sold.

A.R.T. Advisors first reported a position in ARMP in Q2 2017 and held it in 4 quarters. The position peaked at $65K in Q4 2017. 24 funds tracked by Wall St. Rank hold ARMP as of Q3 2018.

  • A.R.T. Advisors reported no remaining Armata Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • A.R.T. Advisors sold 724 Armata Pharmaceuticals shares in Q3 2018, an estimated $11K.
  • A.R.T. Advisors first reported a position in Armata Pharmaceuticals in Q2 2017 and held it in 4 quarters.
  • A.R.T. Advisors's Armata Pharmaceuticals position peaked at $65K in Q4 2017.
  • 24 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q3 2018.

Based on A.R.T. Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.